Pharos launches Verdi platform, acquires Horizon Oncology

Pharos Capital Group LLC has launched Verdi Oncology, an oncology practice and clinical research management company and made its first acquisition for the platform: Lafayette, Indiana-based Horizon Oncology, a provider of oncology and hematology services. No financial terms were disclosed. Wes Chapman will serve as CEO of Verdi.

DealsNorth AmericaUSHealthcareBriefs